MediPal Holdings Corporation (MAHLY)

Market Cap	3.21B
Revenue (ttm)	23.22B
Net Income (ttm)	314.37M
Shares Out	n/a
EPS (ttm)	1.50
PE Ratio	10.20
Forward PE	n/a
Dividend	0.41 (2.50%)
Ex-Dividend Date	Mar 28, 2025

Volume	503
Average Volume	234
Open	16.38
Previous Close	16.50
Day's Range	16.38 - 16.50
52-Week Range	14.03 - 19.07
Beta	0.00
RSI	75.77
Earnings Date	May 13, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,075
• Stock Exchange: OTCMKTS
• Ticker Symbol: MAHLY

Financial Performance

In 2023, MediPal Holdings's revenue was 3.56 trillion, an increase of 5.91% compared to the previous year's 3.36 trillion. Earnings were 41.47 billion, an increase of 6.88%.

Financial numbers in JPY